PRESS RELEASE published on 11/04/2025 at 11:38, 3 months 10 days ago Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research initiates coverage on MaaT Pharma SACA with a BUY rating and EUR 17 price target. MaaT Pharma focuses on microbiome-based therapies for oncology, with high clinical impact and late-stage pipeline Oncology BUY Rating Clinical-stage Biotechnology MaaT Pharma SACA Microbiome-based Therapies
BRIEF published on 11/04/2025 at 07:35, 3 months 10 days ago MaaT Pharma Third Quarter 2025 Financial Results and Financing Update Financial Results MaaT Pharma European Medicines Agency Xervyteg® Clinigen Partnership
BRIEF published on 11/04/2025 at 07:35, 3 months 10 days ago MaaT Pharma : Résultats financiers et mise à jour du financement pour le troisième trimestre 2025 Résultats Financiers MaaT Pharma Agence Européenne Des Médicaments Xervyteg® Partenariat Clinigen
PRESS RELEASE published on 11/04/2025 at 07:30, 3 months 10 days ago Informations privilégiées / Communiqué sur comptes, résultats MaaT Pharma annonce ses activités de financement et résultats financiers T3 2025, incluant un accord avec Clinigen augmentant le CA de 45% Résultats Financiers Croissance Financement MaaT Pharma Accord Clinigen
PRESS RELEASE published on 11/04/2025 at 07:30, 3 months 10 days ago Inside Information / News release on accounts, results MaaT Pharma reports Q3 2025 financial results, secured financing, and partnership updates. Cash position of €22.4 million. Revenues increased by 45% year-over-year Revenues Financing Partnership MaaT Pharma Q3 2025
BRIEF published on 10/13/2025 at 14:52, 4 months 1 day ago Franchissement de Seuils par Invus Public Equities dans MAAT PHARMA Droits De Vote Franchissement De Seuils Cession D'actions MaaT Pharma Invus Public Equities
BRIEF published on 10/13/2025 at 14:52, 4 months 1 day ago Crossing of Thresholds by Invus Public Equities in MAAT PHARMA Voting Rights Crossing Thresholds Transfer Of Shares MaaT Pharma Invus Public Equities
PRESS RELEASE published on 10/13/2025 at 14:47, 4 months 1 day ago Franchissement de seuils Déclaration de franchissement de seuils par Invus Public Equities pour MAAT PHARMA avec 4,96% du capital et des droits de vote suite à une cession d'actions sur le marché Franchissement De Seuils Marché Cession D'actions MaaT Pharma Invus Public Equities
PRESS RELEASE published on 10/07/2025 at 07:30, 4 months 7 days ago Informations privilégiées / Autres communiqués
BRIEF published on 10/06/2025 at 14:59, 4 months 8 days ago Symbiosis LLC réduit sa participation dans MAAT PHARMA Droits De Vote Franchissement De Seuils Cession D'actions MaaT Pharma Symbiosis LLC
Published on 02/14/2026 at 01:00, 1 day 3 hours ago Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:15, 1 day 6 hours ago Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 1 day 10 hours ago Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 1 day 13 hours ago Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Published on 02/14/2026 at 16:30, 11 hours 52 minutes ago Milano Cortina 2026 Licensed Candies Released Globally
Published on 02/14/2026 at 06:05, 22 hours 17 minutes ago The 139th Canton Fair Promotion Conferences to Be Held in Germany and Morocco, Highlighting Targeted Industry Opportunities
Published on 02/13/2026 at 19:20, 1 day 9 hours ago Retail offering successfully completed and update on Euronext Growth Oslo listing
Published on 02/13/2026 at 19:01, 1 day 9 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/13/2026 at 18:20, 1 day 10 hours ago GLOBAL TECHNOLOGY LEADERS LAUNCH TRUSTED TECH ALLIANCE
Published on 02/13/2026 at 18:05, 1 day 10 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 1 day 10 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 1 day 10 hours ago Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 1 day 10 hours ago Nombre total d'actions et droits de vote - janvier 2026
